Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study

Eur J Obstet Gynecol Reprod Biol. 2023 Jan:280:60-63. doi: 10.1016/j.ejogrb.2022.11.001. Epub 2022 Nov 4.

Abstract

Objective: Female ovarian reserve progressively declines with increasing age. Intraovarian injection of platelet-rich plasma (PRP) seems to be an alternative treatment to increase fertility in women. Therefore, this study aimed to evaluate the effect of intra-ovarian infusion of PRP in treating women with poor ovarian reserve.

Materials and methods: In this before-and-after study, 22 infertile women with a poor ovarian reserve who underwent in vitro fertilization with the GnRH antagonist protocol were enrolled. After the oocyte retrieval undergoing vaginal ultrasound guide, PRP was injected into the ovary with a puncture needle under general anesthesia. Finally, the levels of anti-Müllerian hormone (AMH) and antral follicle counts (AFCs) were compared in all participants before and three months after the PRP injection.

Results: Our findings showed that AMH significantly increased after the intra-ovarian infusion of PRP (P < 0.001) in these women, while no significant changes were observed in AFC (P = 0.140) at the end of the study. In addition, logistic regression indicated that body mass index (BMI) and maternal age had no significant effect on ovarian response to PRP injection. However, the duration of infertility > 5 years was associated with a 20-fold increase in the probability of AFC < 7 in women with poor ovarian reserve.

Conclusions: PRP can increase the chance of fertility in women with poor ovarian reserve by significantly increasing AMH levels.

Keywords: Anti-Müllerian hormone; Antral follicle count; Infertility; Platelet-rich plasma.

MeSH terms

  • Anti-Mullerian Hormone
  • Female
  • Fertility
  • Fertilization in Vitro / methods
  • Humans
  • Infertility, Female* / therapy
  • Ovarian Follicle
  • Ovarian Reserve* / physiology
  • Ovulation Induction
  • Platelet-Rich Plasma*

Substances

  • Anti-Mullerian Hormone